Hangzhou Repugene Technology Co., Ltd. is a high-tech advanced biomedical research and development enterprise with the team of Dr. Haigui.
Wang Tao, Director of Digital Health
Market Operations Consultant Mr. Wan Jiang
Mr. Wan Jiang
Senior Vice President of Beida Pharmaceutical;
Bachelor of Clinical Medicine, Capital Medical University;
Chief Clinical Medicine Consultant Professor Wang Yi
Professor Wang Yi
Double Ph.D. in Medicine and Molecular Biology, Arkansas School of Medicine, USA
Ms. Lou Shengqiong
Vice President of Zhejiang Women Entrepreneurs Association;
Executive President of Hangzhou Women Entrepreneurs Association;
Senior investment manager;
Successfully established and managed the Great Wall International Restaurant Chain Group;
Invested in a number of domestic enterprises, covering biomedicine, information security and other fields, its investment in Beida Pharmaceuticals was successfully listed on the Shenzhen GEM in 2016.
Dr. Ding Liming
NPC deputies, famous returnees scholars, national “Thousand Talents Program” experts, leading figures in Chinese pharmaceutical innovation, and also winners of the National Progress Award;
Fully leading Beida Pharmaceutical to complete the listing of “Kemena”, a molecular target drug for lung cancer with completely independent intellectual property rights, to break the monopoly of foreign products in this field;
Investment holding Xcovery, Kananji Medicine, Medical Kono Bio, Beida Anjin and other pharmaceutical companies.
Dr. Lin Rui, Director of Gene Sequencing
Postdoctoral fellow at the Scripps Research Institute
Has provided CRO services to many of the world's top pharmaceutical companies
Discover new tumor marker genes
Create a new high-sensitivity second-generation sequencing method
Dr. Li Nan, Director of Bioinformatics and Big Data
Postdoctoral fellow at the University of California, San Diego
With many years of overseas R&D experience, he has published many important academic papers in Nature.
Expertise: High-throughput sequence analysis, bioinformatics process design and multiple machine learning methods
Chief Medical Consultant Dr. Mao Li
Dr. Mao Li, Senior Vice President and Chief Medical Officer of Beida Pharmaceutical;
a tenured professor at the University of Texas Anderson Cancer Center;
Professor of Changjiang Scholars, School of Medicine, Shanghai Jiaotong University; expert of the National “Thousand Talents Program”;